Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
46.55    -0.90 (-1.90%)
Bid:
47.05
Ask:
47.70
Spread: 0.65 (1.382%)
Market Cap: £185.32m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Dividend Policy Update

11 May 2022 07:00

RNS Number : 0247L
CLS Holdings PLC
11 May 2022
 

 

Release date: 11 May 2022

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS" or the "Group")

Updated Dividend Policy, Proposed Tender Offer and Trading Update

 

CLS, a leading FTSE250 office space specialist with a £2.3 billion portfolio in the UK, Germany and France, today announces an updated dividend policy, a proposed tender offer following the publication of the Group's half yearly financial results on 10 August 2022 and a trading update.

 

Updated Dividend Policy

Following the conversion of its UK business to a REIT, CLS has updated its dividend policy for the 2022 financial year onwards. The company will maintain a progressive dividend policy, with a dividend cover of 1.2 to 1.6 times EPRA earnings (previously 1.5 to 2.0 times). It is expected that FY2022 dividend cover will be around the middle of the new range.

 

Proposed Tender Offer

CLS remains committed to its strategy and business model to drive long-term value including its planned 2022 disposals, which to date have been at or above valuations. Nevertheless, the Board of CLS believes the share price discount to its net tangible assets ("NTA") is unjustified and believes that it is in the best interests of all shareholders to take steps to reduce this discount. 

 

Subject to the completion of a number of property sales by the end of the first half of 2022, and the significant share price discount to NTA persisting, CLS intends to undertake a tender offer of its ordinary shares, the terms of which will be announced following the publication of the Group's half yearly financial results on 10 August 2022. The quantum of any tender offer will be scaled to ensure the Group's loan-to-value is still within an acceptable level by the year-end.

 

Trading Update

CLS continues to trade in line with market expectations.

 

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"I am pleased to announce an enhancement to our dividend policy following the conversion of our UK business to a REIT, which will be applied to all future dividends until further notice. 

 

"The Board is clear that the current share price discount to NTA is unjustified given that we are in the process of disposing of a number of properties at or above 31 December 2021 valuations and the quality of our portfolio is proving resilient in a challenging macro environment. Consequently, CLS intends to undertake a tender offer following the 2022 half yearly financial results."

 

This announcement contains inside information.

-ends-

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Richard CrawleyJamie Richards+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)Alex Simmons

Hastings Tarrant

+44 (0)20 3047 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUQGAUPPPPU
Date   Source Headline
6th Oct 20225:48 pmRNSDirector/PDMR Shareholding
5th Oct 20225:13 pmRNSDirector/PDMR Shareholding
4th Oct 20221:12 pmRNSDirector/PDMR Shareholding
29th Sep 202211:26 amRNSDirector/PDMR Shareholding
23rd Sep 20223:06 pmRNSDirector/PDMR Shareholding
22nd Sep 20223:41 pmRNSDirector/PDMR Shareholding
16th Sep 20224:56 pmRNSCompletion of Tender Offer and Total Voting Rights
15th Sep 20223:57 pmRNSDirector/PDMR Shareholding
12th Sep 20224:14 pmRNSResult of Tender Offer
9th Sep 202212:23 pmRNSResult of AGM
15th Aug 20224:27 pmRNSTender Offer
10th Aug 20224:19 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSHalf-year Results
3rd Aug 20227:00 amRNSCLS announces the sale of three properties
2nd Aug 20225:38 pmRNSNotice of Results
14th Jul 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 202210:31 amRNSCLS reclassified as REIT on EPRA index
9th Jun 20222:09 pmRNSDirector/PDMR Shareholding
12th May 20222:05 pmRNSDirector/PDMR Shareholding
12th May 20222:01 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSDividend Policy Update
28th Apr 20223:24 pmRNSAGM Statement
14th Apr 202211:20 amRNSDirector/PDMR Shareholding
28th Mar 20224:19 pmRNSAnnual Financial Report
18th Mar 202212:54 pmRNSDirector/PDMR Shareholding
18th Mar 202212:52 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSAnnual Financial Report
9th Mar 20225:42 pmRNSDirector/PDMR Shareholding
8th Mar 20227:00 amRNSAcquisition
17th Feb 20227:00 amRNSAcquisition
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
10th Feb 20222:55 pmRNSHolding(s) in Company
9th Feb 20223:50 pmRNSDirector/PDMR Shareholding
9th Feb 202211:50 amRNSDirector/PDMR Shareholding
3rd Feb 202210:10 amRNSNotice of Results
26th Jan 202211:51 amRNSDirector/PDMR Shareholding
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
29th Dec 20211:07 pmRNSConversion of UK operations to a REIT
21st Dec 20216:25 pmRNSPDMR Notification
16th Dec 20217:00 amRNSCLS secures five new leases in Germany
9th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20219:52 amRNSDirector Declaration
11th Nov 202111:40 amRNSDirector/PDMR Shareholding
9th Nov 20219:24 amRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSTrading Update
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSCLS secures two new leases in Germany
20th Sep 20215:43 pmRNSDirector/PDMR Shareholding
10th Sep 20215:26 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.